8-Carboxamidocyclazocine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "8-Carboxamidocyclazocine" in English language version.

refsWebsite

Global rank English rank

13nih.gov

4^th place

9doi.org

2^nd place

1semanticscholar.org

11^th place

8^th place

doi.org

Wentland MP, Lou R, Ye Y, Cohen DJ, Richardson GP, Bidlack JM (March 2001). "8-Carboxamidocyclazocine analogues: redefining the structure-activity relationships of 2,6-methano-3-benzazocines". Bioorganic & Medicinal Chemistry Letters. 11 (5): 623–6. doi:10.1016/S0960-894X(01)00014-2. PMID 11266156.
Bidlack JM, Cohen DJ, McLaughlin JP, Lou R, Ye Y, Wentland MP (July 2002). "8-Carboxamidocyclazocine: a long-acting, novel benzomorphan". The Journal of Pharmacology and Experimental Therapeutics. 302 (1): 374–80. doi:10.1124/jpet.302.1.374. PMID 12065740. S2CID 15864569.
Stevenson GW, Wentland MP, Bidlack JM, Mello NK, Negus SS (December 2004). "Effects of the mixed-action kappa/mu opioid agonist 8-carboxamidocyclazocine on cocaine- and food-maintained responding in rhesus monkeys". European Journal of Pharmacology. 506 (2): 133–41. doi:10.1016/j.ejphar.2004.10.051. PMID 15588733.
Wentland MP, VanAlstine M, Kucejko R, Lou R, Cohen DJ, Parkhill AL, Bidlack JM (September 2006). "Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine". Journal of Medicinal Chemistry. 49 (18): 5635–9. doi:10.1021/jm060278n. PMID 16942039.
VanAlstine MA, Wentland MP, Cohen DJ, Bidlack JM (December 2007). "Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 5. Opioid receptor binding properties of N-((4'-phenyl)-phenethyl) analogues of 8-CAC". Bioorganic & Medicinal Chemistry Letters. 17 (23): 6516–20. doi:10.1016/j.bmcl.2007.09.082. PMC 2137165. PMID 17935988.
Wentland MP, Sun X, Cohen DJ, Bidlack JM (May 2008). "Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 6: Opioid receptor binding properties of cyclic variants of 8-carboxamidocyclazocine". Bioorganic & Medicinal Chemistry. 16 (10): 5653–64. doi:10.1016/j.bmc.2008.03.066. PMC 2441872. PMID 18417347.
Wentland MP, Lu Q, Ganorkar R, Zhang SZ, Jo S, Cohen DJ, Bidlack JM (January 2009). "Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 7: syntheses and opioid receptor properties of cyclic variants of cyclazocine". Bioorganic & Medicinal Chemistry Letters. 19 (2): 365–8. doi:10.1016/j.bmcl.2008.11.076. PMID 19091564.
Wentland MP, Lou R, Lu Q, Bu Y, Denhardt C, Jin J, et al. (April 2009). "Syntheses of novel high affinity ligands for opioid receptors". Bioorganic & Medicinal Chemistry Letters. 19 (8): 2289–94. doi:10.1016/j.bmcl.2009.02.078. PMC 2791460. PMID 19282177.
Prisinzano TE, Tidgewell K, Harding WW (October 2005). "Kappa opioids as potential treatments for stimulant dependence". The AAPS Journal. 7 (3): E592-9. doi:10.1208/aapsj070361. PMC 2751263. PMID 16353938.

nih.gov

pubmed.ncbi.nlm.nih.gov

Wentland MP, Lou R, Ye Y, Cohen DJ, Richardson GP, Bidlack JM (March 2001). "8-Carboxamidocyclazocine analogues: redefining the structure-activity relationships of 2,6-methano-3-benzazocines". Bioorganic & Medicinal Chemistry Letters. 11 (5): 623–6. doi:10.1016/S0960-894X(01)00014-2. PMID 11266156.
Bidlack JM, Cohen DJ, McLaughlin JP, Lou R, Ye Y, Wentland MP (July 2002). "8-Carboxamidocyclazocine: a long-acting, novel benzomorphan". The Journal of Pharmacology and Experimental Therapeutics. 302 (1): 374–80. doi:10.1124/jpet.302.1.374. PMID 12065740. S2CID 15864569.
Stevenson GW, Wentland MP, Bidlack JM, Mello NK, Negus SS (December 2004). "Effects of the mixed-action kappa/mu opioid agonist 8-carboxamidocyclazocine on cocaine- and food-maintained responding in rhesus monkeys". European Journal of Pharmacology. 506 (2): 133–41. doi:10.1016/j.ejphar.2004.10.051. PMID 15588733.
Wentland MP, VanAlstine M, Kucejko R, Lou R, Cohen DJ, Parkhill AL, Bidlack JM (September 2006). "Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine". Journal of Medicinal Chemistry. 49 (18): 5635–9. doi:10.1021/jm060278n. PMID 16942039.
VanAlstine MA, Wentland MP, Cohen DJ, Bidlack JM (December 2007). "Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 5. Opioid receptor binding properties of N-((4'-phenyl)-phenethyl) analogues of 8-CAC". Bioorganic & Medicinal Chemistry Letters. 17 (23): 6516–20. doi:10.1016/j.bmcl.2007.09.082. PMC 2137165. PMID 17935988.
Wentland MP, Sun X, Cohen DJ, Bidlack JM (May 2008). "Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 6: Opioid receptor binding properties of cyclic variants of 8-carboxamidocyclazocine". Bioorganic & Medicinal Chemistry. 16 (10): 5653–64. doi:10.1016/j.bmc.2008.03.066. PMC 2441872. PMID 18417347.
Wentland MP, Lu Q, Ganorkar R, Zhang SZ, Jo S, Cohen DJ, Bidlack JM (January 2009). "Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 7: syntheses and opioid receptor properties of cyclic variants of cyclazocine". Bioorganic & Medicinal Chemistry Letters. 19 (2): 365–8. doi:10.1016/j.bmcl.2008.11.076. PMID 19091564.
Wentland MP, Lou R, Lu Q, Bu Y, Denhardt C, Jin J, et al. (April 2009). "Syntheses of novel high affinity ligands for opioid receptors". Bioorganic & Medicinal Chemistry Letters. 19 (8): 2289–94. doi:10.1016/j.bmcl.2009.02.078. PMC 2791460. PMID 19282177.
Prisinzano TE, Tidgewell K, Harding WW (October 2005). "Kappa opioids as potential treatments for stimulant dependence". The AAPS Journal. 7 (3): E592-9. doi:10.1208/aapsj070361. PMC 2751263. PMID 16353938.

ncbi.nlm.nih.gov

VanAlstine MA, Wentland MP, Cohen DJ, Bidlack JM (December 2007). "Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 5. Opioid receptor binding properties of N-((4'-phenyl)-phenethyl) analogues of 8-CAC". Bioorganic & Medicinal Chemistry Letters. 17 (23): 6516–20. doi:10.1016/j.bmcl.2007.09.082. PMC 2137165. PMID 17935988.
Wentland MP, Sun X, Cohen DJ, Bidlack JM (May 2008). "Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 6: Opioid receptor binding properties of cyclic variants of 8-carboxamidocyclazocine". Bioorganic & Medicinal Chemistry. 16 (10): 5653–64. doi:10.1016/j.bmc.2008.03.066. PMC 2441872. PMID 18417347.
Wentland MP, Lou R, Lu Q, Bu Y, Denhardt C, Jin J, et al. (April 2009). "Syntheses of novel high affinity ligands for opioid receptors". Bioorganic & Medicinal Chemistry Letters. 19 (8): 2289–94. doi:10.1016/j.bmcl.2009.02.078. PMC 2791460. PMID 19282177.
Prisinzano TE, Tidgewell K, Harding WW (October 2005). "Kappa opioids as potential treatments for stimulant dependence". The AAPS Journal. 7 (3): E592-9. doi:10.1208/aapsj070361. PMC 2751263. PMID 16353938.

semanticscholar.org

api.semanticscholar.org

Bidlack JM, Cohen DJ, McLaughlin JP, Lou R, Ye Y, Wentland MP (July 2002). "8-Carboxamidocyclazocine: a long-acting, novel benzomorphan". The Journal of Pharmacology and Experimental Therapeutics. 302 (1): 374–80. doi:10.1124/jpet.302.1.374. PMID 12065740. S2CID 15864569.